18 insiders have filed at BMY since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Leung Sandra | EVP, General Counsel | 465.4k | 0.023% | ||
| Caforio Giovanni | Executive Chair Of The Board | 432.3k | 0.021% | ||
| Elkins David V | EVP, Chief Financial Officer | 189.5k | <0.01% | 1 sells $2.7M | |
| Boerner Christopher S. | Chief Executive Officer | 146.9k | <0.01% | 3 buys $360k | |
| Hirawat Samit | EVP,chief Med.Offr.,drug Dev. | 83.5k | <0.01% | 3 buys $402k | |
| Samuels Theodore R. II | Director | 35.5k | <0.01% | 1 buys $423k | |
| Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | 30.4k | <0.01% | ||
| Lenkowsky Adam | EVP, Chief Commercial Officer | 27.9k | <0.01% | ||
| Powell Ann | EVP, Chief Human Resources | 27.9k | <0.01% | 1 sells $1.1M | |
| Shanahan Karin | EVP, Chief Supply Chain & Ops | 25.6k | <0.01% | ||
| Plenge Robert M | EVP, Chief Research Officer | 24.8k | <0.01% | 1 sells $45k | |
| Holzer Phil M | SVP And Controller | 17.4k | <0.01% | 1 sells $39k | |
| Hickey Benjamin | President, Rayzebio Org. | 16.7k | <0.01% | 1 sells $4k | |
| Gallman Cari | EVP, General Counsel | 13.1k | <0.01% | ||
| Hoch Lynelle | President, Cell Therapy Org. | 8.2k | <0.01% | ||
| Short Bartie Wendy | EVP, Corporate Affairs | 7.9k | <0.01% | 1 sells $17k | |
| Poole Ahn Amanda | EVP, Chief People Officer | 7.3k | <0.01% | ||
| Weese Michelle | EVP, Corporate Affairs | 3.5k | <0.01% |
Full register at boothcheck.com/insiders/BMY. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.